Shares of Ariad Pharmaceuticals Inc. fell sharply yesterday even as the broad market posted gains. The stock closed 1.02% lower at $18.51 on above average volume of 3.59 million. Despite the losses seen on Monday, Ariad Pharma's shares are still up more than 1.40% in the last three trading sessions. Year-to-date, the stock is down nearly 3.50%. However, the biotech company's shares have seen a series of highs over the past few trading sessions, which suggests that market sentiment has turned bullish on the stock. Register today and access the free research on ARIA at
ZIOPHARM Oncology Inc.'s shares struggled in Monday's trading session, reversing some of the recent gains. The stock fell to an intra-day low of $1.67 before finishing the day 2.33% lower at $1.68 on volume of 760,400. Despite the losses yesterday, ZIOPHARM's shares gained more than 4.30% in the last three sessions. The stock's MACD has just crossed above the signal line, which suggests that market sentiment has once again turned bullish on ZIOP. Year-to-date, the company's shares are down nearly 60%. The free report on ZIOP can be downloaded by signing up now at
Galena Biopharma Inc. shares fell sharply yesterday. The stock traded between $2.30 and $2.46 before finishing the day 3.33% lower at $2.32 on above average volume of 2.12 million. Despite the losses, Galena's shares are still trading close to their 52-week high of $2.60. The stock has had an excellent run so far in 2013, jumping more than 51%, compared to a gain of more than 9.50% for the S&P 500. Free report on GALE can be accessed by registering at
Novavax Inc.'s shares edged
Copyright©2012 PR Newswire.
All rights reserved